Evidence map›Paper›PMID 35192612›Full record

ArticlePLoS genetics2022

Chondroitin/dermatan sulfate glycosyltransferase genes are essential for craniofacial development.

Judith Habicher, Gaurav K Varshney, Laura Waldmann, Daniel Snitting, Amin Allalou, Hanqing Zhang, Abdurrahman Ghanem, Caroline Öhman Mägi, Tabea Dierker, Lena Kjellén and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Judith HabicherDepartment of Organismal Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-8691-8650
Gaurav K VarshneyGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.ORCID 0000-0002-0429-1904
Laura WaldmannDepartment of Organismal Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-3619-0796
Daniel SnittingDepartment of Organismal Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-9704-6336
Amin AllalouDepartment of Information Technology, and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-4028-8443
Hanqing ZhangDepartment of Immunology, Genetics and Pathology, Medical Genetics and Genomics, Uppsala University, Uppsala, Sweden.
Abdurrahman GhanemDepartment for Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-4388-6222
Caroline Öhman MägiDepartment for Engineering Sciences, Applied Materials Science, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-2709-9541
Tabea DierkerDepartment for Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-1991-2723
Lena KjellénDepartment for Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Shawn M BurgessTranslational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America.ORCID 0000-0003-1147-0596
Johan LedinDepartment of Organismal Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-7319-7735
Uppsala University · SENational Institutes of Health · USOklahoma Medical Research Foundation · US

Funding

Zebrafish targeted mutagenesis and functional genomicsZIAHG000183 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BURGESS, SHAWN M · 2009 to 2025
$16.7M
Intramural NIH HHS ZIA HG000183
6 · The paper itself

Abstract

Chondroitin/dermatan sulfate (CS/DS) proteoglycans are indispensable for animal development and homeostasis but the large number of enzymes involved in their biosynthesis have made CS/DS function a challenging problem to study genetically. In our study, we generated loss-of-function alleles in zebrafish genes encoding CS/DS biosynthetic enzymes and characterized the effect on development in single and double mutants. Homozygous mutants in chsy1, csgalnact1a, csgalnat2, chpfa, ust and chst7, respectively, develop to adults. However, csgalnact1a-/- fish develop distinct craniofacial defects while the chsy1-/- skeletal phenotype is milder and the remaining mutants display no gross morphological abnormalities. These results suggest a high redundancy for the CS/DS biosynthetic enzymes and to further reduce CS/DS biosynthesis we combined mutant alleles. The craniofacial phenotype is further enhanced in csgalnact1a-/-;chsy1-/- adults and csgalnact1a-/-;csgalnact2-/- larvae. While csgalnact1a-/-;csgalnact2-/- was the most affected allele combination in our study, CS/DS is still not completely abolished. Transcriptome analysis of chsy1-/-, csgalnact1a-/- and csgalnact1a-/-;csgalnact2-/- larvae revealed that the expression had changed in a similar way in the three mutant lines but no differential expression was found in any of fifty GAG biosynthesis enzymes identified. Thus, zebrafish larvae do not increase transcription of GAG biosynthesis genes as a consequence of decreased CS/DS biosynthesis. The new zebrafish lines develop phenotypes similar to clinical characteristics of several human congenital disorders making the mutants potentially useful to study disease mechanisms and treatment.

Indexed as

Dermatan SulfateZebrafishAnimalsChondroitin SulfatesGlycosyltransferasesPhenotypeChondroitin SulfatesDermatan SulfateGlycosyltransferases

Identifiers

PMID35192612
PMCPMC8896900
OpenAlexW4213114481

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.